Podcast Episodes

Back to Search
Rational Use of New and Emerging Agents for Hepatitis Delta Virus
Rational Use of New and Emerging Agents for Hepatitis Delta Virus

Episode 142

Hepatitis delta virus (HDV) is the most severe form of viral hepatitis and warrants new treatment options for better efficacy and tolerability. In pa…

4 years ago

Short Long
View Episode
Conference Conversations: HIV Advanced Practice Provider Perspectives from CROI 2022
Conference Conversations: HIV Advanced Practice Provider Perspectives from CROI 2022

Episode 148

In this episode, Jeffrey Kwong, DNP, MPH, FAANP, FAAN, and Susan LeLacheur, DrPH, PA-C, AAHIVS, share insights on new HIV data from CROI 2022, includ…

4 years ago

Short Long
View Episode
Conference Conversations: HIV Pharmacist Perspectives from CROI 2022
Conference Conversations: HIV Pharmacist Perspectives from CROI 2022

Episode 147

In this episode, Fidelia Bernice, PharmD, and Jennifer Cocohoba, PharmD, share insights on new HIV data from CROI 2022, including:

Islatravir tissue a…

4 years ago

Short Long
View Episode
HABP/VABP and Gram-Negative Resistance: Pathways to Early Effective Therapy
HABP/VABP and Gram-Negative Resistance: Pathways to Early Effective Therapy

Episode 146

In this episode, Keith S. Kaye, MD, MPH; Lilian Abbo, MD, FIDSA; and Jason M. Pogue, PharmD, discuss HABP/VABP and gram-negative resistance including…

4 years ago

Short Long
View Episode
Lessons From Lockdown: Viral Hepatitis Testing and Treatment in the COVID-19 Era—Audio Recap
Lessons From Lockdown: Viral Hepatitis Testing and Treatment in the COVID-19 Era—Audio Recap

Episode 138

In this episode, Jordan J. Feld, MD, MPH, and Nancy Reau, MD, share lessons learned in the testing and treatment of viral hepatitis in the COVID-19 e…

4 years ago

Short Long
View Episode
Key HIV Studies Influencing My Practice Following CROI 2022—Audio Recap
Key HIV Studies Influencing My Practice Following CROI 2022—Audio Recap

Episode 145

In this episode, Daniel R. Kuritzkes, MD, and David A. Wohl, MD, discuss new HIV data from CROI 2022, including:

Prevention strategiesLA therapiesSeco…

4 years ago

Short Long
View Episode
Key Decisions in HIV Care: Data on Long-Acting Injectable PrEP
Key Decisions in HIV Care: Data on Long-Acting Injectable PrEP

Episode 144

In this episode, Jason Schafer, PharmD, MPH, explores the data for long-acting injectable pre-exposure prophylaxis (PrEP).

Listen as he gives his pers…

4 years ago

Short Long
View Episode
Key Decisions in HIV Care: ART Considerations in the Inpatient Setting
Key Decisions in HIV Care: ART Considerations in the Inpatient Setting

Episode 143

In this episode, Jason Schafer, PharmD, MPH, explores recommendations and data on managing antiretroviral therapy (ART) in the inpatient setting.

List…

4 years ago

Short Long
View Episode
Monitoring and Treating Patients Coinfected With HBV and HDV
Monitoring and Treating Patients Coinfected With HBV and HDV

Episode 141

Hepatitis delta virus (HDV) only exists in patients with hepatitis B virus (HBV) coinfection. In part 1 of this 2-part podcast series, hear Heiner We…

4 years ago

Short Long
View Episode
Starting HBV Treatment in Pregnancy: Conversations Between Patient and Physician #3
Starting HBV Treatment in Pregnancy: Conversations Between Patient and Physician #3

Episode 140

Episode 3 of this series features Anna Cristina L. dela Cruz, MD, in conversation with patient Melody Cheng about Melody’s decision to start hepatiti…

4 years ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us